Fredun Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

4.53

4.43

3.99

3.99

3.99

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

91.84

63.63

39.08

37.33

35.00

Loan funds

Secured loans

86.53

52.76

39.64

34.90

-

Unsecured loans

-

-

-

-

-

Total

182.90

120.83

82.71

76.22

38.99

Uses of funds

Fixed assets

Gross block

51.34

32.34

30.35

30.97

41.40

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

12.40

-

-

-

10.04

Net block

38.93

32.34

30.35

30.97

31.35

Capital work-in-progress

-

-

-

-

-

Investments

0.31

0.06

0.06

0.05

0.01

Net current assets

Current assets, loans & advances

218.04

154.59

131.21

102.14

73.55

Less : current liabilities & provisions

74.38

66.16

78.91

56.94

65.92

Total net current assets

143.66

88.43

52.30

45.20

7.63

Miscellaneous expenses not written

-

-

-

-

-

Total

182.90

120.83

82.71

76.22

38.99

Notes:

Book value of unquoted investments

-

0.06

0.06

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

45.32

44.33

39.90

39.90

39.90